Friday June 23rd 2017

The use of complementary and alternative medicine in patients with multiple sclerosis: A longitudinal study.

This study captured the using of CAM of MS patients in combination with disease progression. METHODS: 119 Patients with MS were asked about CAM utilization, sociodemographic and disease factors within the context of a semistructured interview at an interval of seven years. The depressive status was ascertained with the Beck’s Depression Inventory (BDI). Differences of users and non-users were checked with diverse statistical tests. RESULTS: Comparing both isolated measurements at second point less patients used CAM accompanied by worse socioeconomic situation and progression of the disease. Patients use CAM in a stage of illness, characterized by the Established Disability Status Scale (EDSS) between 3.5 and 4.0 points, signifying a transition from moderate to severe impairment, an…

Read More: 

The use of complementary and alternative medicine in patients with multiple sclerosis: A longitudinal study.

Leave a Comment

More from category

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation
MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill
MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Type I interferons could have role in natural improvement of RA during pregnancy
Type I interferons could have role in natural improvement of RA during pregnancy

An international US-Danish team of scientists, led by Damini Jawaheer, Ph.D. at the UCSF Benioff Children's Hospital [Read More]

Shared decision-making essential to optimal treatment and quality of life for patients with MS
Shared decision-making essential to optimal treatment and quality of life for patients with MS

One of the cornerstones of multiple sclerosis treatment is shared decision-making between patients and their doctors [Read More]

UC consortium formed to speed up development of new drugs
UC consortium formed to speed up development of new drugs

For 12 years, UCLA researcher Dennis Slamon pursued a groundbreaking approach to treating breast cancer: Attack the [Read More]